25 XP   0   0   10

Jianmin Pharmaceutical Group Co Ltd
Buy, Hold or Sell?

Let's analyse Jianmin Pharmaceutical Group Co Ltd together

PenkeI guess you are interested in Jianmin Pharmaceutical Group Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jianmin Pharmaceutical Group Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Jianmin Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Jianmin Pharmaceutical Group Co Ltd.

Quick analysis of Jianmin Pharmaceutical Group Co Ltd (30 sec.)










What can you expect buying and holding a share of Jianmin Pharmaceutical Group Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.14
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
¥14.71
Expected worth in 1 year
¥17.24
How sure are you?
97.5%

+ What do you gain per year?

Total Gains per Share
¥3.55
Return On Investment
6.4%

For what price can you sell your share?

Current Price per Share
¥55.64
Expected price per share
¥44.39 - ¥61.70
How sure are you?
50%

1. Valuation of Jianmin Pharmaceutical Group Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥55.64

Intrinsic Value Per Share

¥8.21 - ¥21.25

Total Value Per Share

¥22.92 - ¥35.96

2. Growth of Jianmin Pharmaceutical Group Co Ltd (5 min.)




Is Jianmin Pharmaceutical Group Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$311.3m$239.8m$48m16.7%

How much money is Jianmin Pharmaceutical Group Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$17.9m$14m$3.9m21.8%
Net Profit Margin12.5%11.1%--

How much money comes from the company's main activities?

3. Financial Health of Jianmin Pharmaceutical Group Co Ltd (5 min.)




What can you expect buying and holding a share of Jianmin Pharmaceutical Group Co Ltd? (5 min.)

Welcome investor! Jianmin Pharmaceutical Group Co Ltd's management wants to use your money to grow the business. In return you get a share of Jianmin Pharmaceutical Group Co Ltd.

What can you expect buying and holding a share of Jianmin Pharmaceutical Group Co Ltd?

First you should know what it really means to hold a share of Jianmin Pharmaceutical Group Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Jianmin Pharmaceutical Group Co Ltd is ¥55.64. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jianmin Pharmaceutical Group Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jianmin Pharmaceutical Group Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥14.71. Based on the TTM, the Book Value Change Per Share is ¥0.63 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.49 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.26 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jianmin Pharmaceutical Group Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.100.2%0.130.2%0.090.2%0.070.1%0.040.1%
Usd Book Value Change Per Share0.100.2%0.090.2%0.070.1%0.070.1%0.030.1%
Usd Dividend Per Share0.000.0%0.040.1%0.030.1%0.020.0%0.020.0%
Usd Total Gains Per Share0.100.2%0.120.2%0.100.2%0.090.2%0.050.1%
Usd Price Per Share9.00-9.84-6.93-5.82-4.72-
Price to Earnings Ratio23.53-19.42-19.86-27.11-44.02-
Price-to-Total Gains Ratio86.98-84.16-75.86-99.64-118.27-
Price to Book Ratio4.44-5.28-4.46-4.19-4.26-
Price-to-Total Gains Ratio86.98-84.16-75.86-99.64-118.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.67832
Number of shares130
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.02
Usd Book Value Change Per Share0.090.07
Usd Total Gains Per Share0.120.09
Gains per Quarter (130 shares)15.9411.61
Gains per Year (130 shares)63.7646.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1184554103736
23791118197382
35513618229110128
47318224639147174
59222731048184220
611027337458220266
712831843868257312
814636450277294358
916540956687331404
1018345563097367450

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%77.00.01.098.7%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%18.02.00.090.0%33.07.00.082.5%62.016.00.079.5%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%36.00.04.090.0%71.00.07.091.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.01.00.097.5%73.05.00.093.6%

Fundamentals of Jianmin Pharmaceutical Group Co Ltd

About Jianmin Pharmaceutical Group Co Ltd

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells medicines in China. The company operates through Drug production and sales, Commercial, and Medical segments. It offers medicines and pediatric drugs under the Jianmin, Longmu, and Yekaitai brand name. The company also provides OTC and medical products, as well as consultation service. Further, it provides medical services, such as outpatient, hospitalization, and health management. Jianmin Pharmaceutical Group Co.,Ltd. was founded in 1993 and is headquartered in Wuhan, China.

Fundamental data was last updated by Penke on 2024-04-18 00:40:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Jianmin Pharmaceutical Group Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Jianmin Pharmaceutical Group Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Jianmin Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 9.7% means that ¥0.10 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jianmin Pharmaceutical Group Co Ltd:

  • The MRQ is 9.7%. The company is making a profit. +1
  • The TTM is 12.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ9.7%TTM12.5%-2.8%
TTM12.5%YOY11.1%+1.3%
TTM12.5%5Y8.8%+3.7%
5Y8.8%10Y6.5%+2.3%
1.1.2. Return on Assets

Shows how efficient Jianmin Pharmaceutical Group Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Jianmin Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.6% Return on Assets means that Jianmin Pharmaceutical Group Co Ltd generated ¥0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jianmin Pharmaceutical Group Co Ltd:

  • The MRQ is 2.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.6%TTM3.4%-0.8%
TTM3.4%YOY3.3%+0.1%
TTM3.4%5Y2.5%+0.9%
5Y2.5%10Y1.9%+0.6%
1.1.3. Return on Equity

Shows how efficient Jianmin Pharmaceutical Group Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Jianmin Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.7% Return on Equity means Jianmin Pharmaceutical Group Co Ltd generated ¥0.05 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jianmin Pharmaceutical Group Co Ltd:

  • The MRQ is 4.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 6.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.7%TTM6.3%-1.6%
TTM6.3%YOY5.9%+0.4%
TTM6.3%5Y4.5%+1.8%
5Y4.5%10Y3.4%+1.2%

1.2. Operating Efficiency of Jianmin Pharmaceutical Group Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Jianmin Pharmaceutical Group Co Ltd is operating .

  • Measures how much profit Jianmin Pharmaceutical Group Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Jianmin Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jianmin Pharmaceutical Group Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.4%-2.4%
TTM2.4%YOY7.2%-4.8%
TTM2.4%5Y5.3%-2.9%
5Y5.3%10Y2.7%+2.5%
1.2.2. Operating Ratio

Measures how efficient Jianmin Pharmaceutical Group Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.49 means that the operating costs are ¥1.49 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Jianmin Pharmaceutical Group Co Ltd:

  • The MRQ is 1.487. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.452. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.487TTM1.452+0.035
TTM1.452YOY1.476-0.024
TTM1.4525Y1.506-0.054
5Y1.50610Y1.190+0.315

1.3. Liquidity of Jianmin Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Jianmin Pharmaceutical Group Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.49 means the company has ¥1.49 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Jianmin Pharmaceutical Group Co Ltd:

  • The MRQ is 1.489. The company is just able to pay all its short-term debts.
  • The TTM is 1.526. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.489TTM1.526-0.037
TTM1.526YOY1.562-0.036
TTM1.5265Y1.604-0.078
5Y1.60410Y0.947+0.657
1.3.2. Quick Ratio

Measures if Jianmin Pharmaceutical Group Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Jianmin Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.84 means the company can pay off ¥0.84 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jianmin Pharmaceutical Group Co Ltd:

  • The MRQ is 0.836. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.951. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.836TTM0.951-0.115
TTM0.951YOY1.131-0.180
TTM0.9515Y1.119-0.167
5Y1.11910Y1.078+0.040

1.4. Solvency of Jianmin Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Jianmin Pharmaceutical Group Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Jianmin Pharmaceutical Group Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.46 means that Jianmin Pharmaceutical Group Co Ltd assets are financed with 45.9% credit (debt) and the remaining percentage (100% - 45.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jianmin Pharmaceutical Group Co Ltd:

  • The MRQ is 0.459. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.460. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.459TTM0.460-0.001
TTM0.460YOY0.447+0.013
TTM0.4605Y0.423+0.037
5Y0.42310Y0.401+0.022
1.4.2. Debt to Equity Ratio

Measures if Jianmin Pharmaceutical Group Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Jianmin Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 85.0% means that company has ¥0.85 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jianmin Pharmaceutical Group Co Ltd:

  • The MRQ is 0.850. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.854. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.850TTM0.854-0.003
TTM0.854YOY0.812+0.042
TTM0.8545Y0.746+0.107
5Y0.74610Y0.687+0.059

2. Market Valuation of Jianmin Pharmaceutical Group Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Jianmin Pharmaceutical Group Co Ltd generates.

  • Above 15 is considered overpriced but always compare Jianmin Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 23.53 means the investor is paying ¥23.53 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jianmin Pharmaceutical Group Co Ltd:

  • The EOD is 20.067. Based on the earnings, the company is fair priced.
  • The MRQ is 23.533. Based on the earnings, the company is fair priced.
  • The TTM is 19.421. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD20.067MRQ23.533-3.466
MRQ23.533TTM19.421+4.111
TTM19.421YOY19.857-0.436
TTM19.4215Y27.109-7.688
5Y27.10910Y44.024-16.914
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jianmin Pharmaceutical Group Co Ltd:

  • The EOD is 27.964. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 32.793. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 12.882. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD27.964MRQ32.793-4.830
MRQ32.793TTM12.882+19.911
TTM12.882YOY-29.064+41.946
TTM12.8825Y8.405+4.477
5Y8.40510Y17.998-9.594
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Jianmin Pharmaceutical Group Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Jianmin Pharmaceutical Group Co Ltd:

  • The EOD is 3.782. Based on the equity, the company is fair priced.
  • The MRQ is 4.436. Based on the equity, the company is fair priced.
  • The TTM is 5.280. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD3.782MRQ4.436-0.653
MRQ4.436TTM5.280-0.844
TTM5.280YOY4.465+0.815
TTM5.2805Y4.186+1.094
5Y4.18610Y4.260-0.074
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Jianmin Pharmaceutical Group Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.7380.633+16%0.488+51%0.512+44%0.214+244%
Book Value Per Share--14.71013.600+8%11.330+30%9.623+53%7.933+85%
Current Ratio--1.4891.526-2%1.562-5%1.604-7%0.947+57%
Debt To Asset Ratio--0.4590.4600%0.447+3%0.423+8%0.401+14%
Debt To Equity Ratio--0.8500.8540%0.812+5%0.746+14%0.687+24%
Dividend Per Share--0.0120.255-95%0.202-94%0.135-91%0.150-92%
Eps--0.6930.937-26%0.664+4%0.494+40%0.314+121%
Free Cash Flow Per Share--0.4970.332+50%0.241+106%0.216+130%0.175+184%
Free Cash Flow To Equity Per Share--0.4970.332+50%-0.068+114%0.118+322%0.116+328%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--21.250--------
Intrinsic Value_10Y_min--8.206--------
Intrinsic Value_1Y_max--1.342--------
Intrinsic Value_1Y_min--0.727--------
Intrinsic Value_3Y_max--4.631--------
Intrinsic Value_3Y_min--2.280--------
Intrinsic Value_5Y_max--8.645--------
Intrinsic Value_5Y_min--3.925--------
Market Cap8535120805.120-17%10009285272.00010932747300.160-8%7706382664.400+30%6732558329.700+49%5625097746.131+78%
Net Profit Margin--0.0970.125-22%0.111-13%0.088+10%0.065+50%
Operating Margin---0.024-100%0.072-100%0.053-100%0.027-100%
Operating Ratio--1.4871.452+2%1.476+1%1.506-1%1.190+25%
Pb Ratio3.782-17%4.4365.280-16%4.465-1%4.186+6%4.260+4%
Pe Ratio20.067-17%23.53319.421+21%19.857+19%27.109-13%44.024-47%
Price Per Share55.640-17%65.25071.270-8%50.238+30%42.188+55%34.205+91%
Price To Free Cash Flow Ratio27.964-17%32.79312.882+155%-29.064+189%8.405+290%17.998+82%
Price To Total Gains Ratio74.173-17%86.98584.157+3%75.860+15%99.643-13%118.272-26%
Quick Ratio--0.8360.951-12%1.131-26%1.119-25%1.078-22%
Return On Assets--0.0260.034-25%0.033-22%0.025+0%0.019+32%
Return On Equity--0.0470.063-25%0.059-20%0.045+4%0.034+41%
Total Gains Per Share--0.7500.889-16%0.690+9%0.647+16%0.365+106%
Usd Book Value--311394871.702287892148.201+8%239855571.239+30%213506325.269+46%178620001.082+74%
Usd Book Value Change Per Share--0.1020.087+16%0.067+51%0.071+44%0.030+244%
Usd Book Value Per Share--2.0301.877+8%1.564+30%1.328+53%1.095+85%
Usd Dividend Per Share--0.0020.035-95%0.028-94%0.019-91%0.021-92%
Usd Eps--0.0960.129-26%0.092+4%0.068+40%0.043+121%
Usd Free Cash Flow--10530160.4377034139.757+50%5102588.452+106%4416505.924+138%3212208.175+228%
Usd Free Cash Flow Per Share--0.0690.046+50%0.033+106%0.030+130%0.024+184%
Usd Free Cash Flow To Equity Per Share--0.0690.046+50%-0.009+114%0.016+322%0.016+328%
Usd Market Cap1177846671.107-17%1381281367.5361508719127.422-8%1063480807.687+30%929093049.499+49%776263488.966+78%
Usd Price Per Share7.678-17%9.0059.835-8%6.933+30%5.822+55%4.720+91%
Usd Profit--14674053.11017990289.871-18%14061133.701+4%10301991.604+42%6662515.571+120%
Usd Revenue--151183882.545145353832.768+4%125607616.460+20%109206797.571+38%93497729.405+62%
Usd Total Gains Per Share--0.1040.123-16%0.095+9%0.089+16%0.050+106%
 EOD+4 -4MRQTTM+16 -19YOY+21 -145Y+24 -1110Y+24 -11

3.2. Fundamental Score

Let's check the fundamental score of Jianmin Pharmaceutical Group Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.067
Price to Book Ratio (EOD)Between0-13.782
Net Profit Margin (MRQ)Greater than00.097
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.836
Current Ratio (MRQ)Greater than11.489
Debt to Asset Ratio (MRQ)Less than10.459
Debt to Equity Ratio (MRQ)Less than10.850
Return on Equity (MRQ)Greater than0.150.047
Return on Assets (MRQ)Greater than0.050.026
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Jianmin Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.440
Ma 20Greater thanMa 5056.273
Ma 50Greater thanMa 10055.738
Ma 100Greater thanMa 20058.811
OpenGreater thanClose55.290
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets4,167,951
Total Liabilities1,911,467
Total Stockholder Equity2,247,706
 As reported
Total Liabilities 1,911,467
Total Stockholder Equity+ 2,247,706
Total Assets = 4,167,951

Assets

Total Assets4,167,951
Total Current Assets2,765,892
Long-term Assets1,402,059
Total Current Assets
Cash And Cash Equivalents 305,122
Short-term Investments 694,456
Net Receivables 858,462
Inventory 450,845
Other Current Assets 44,411
Total Current Assets  (as reported)2,765,892
Total Current Assets  (calculated)2,353,296
+/- 412,596
Long-term Assets
Property Plant Equipment 450,703
Goodwill 214
Intangible Assets 33,987
Long-term Assets Other 12,379
Long-term Assets  (as reported)1,402,059
Long-term Assets  (calculated)497,283
+/- 904,776

Liabilities & Shareholders' Equity

Total Current Liabilities1,856,942
Long-term Liabilities54,525
Total Stockholder Equity2,247,706
Total Current Liabilities
Short Long Term Debt 79,445
Accounts payable 782,911
Other Current Liabilities 676,329
Total Current Liabilities  (as reported)1,856,942
Total Current Liabilities  (calculated)1,538,686
+/- 318,257
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt30,294
Long-term Liabilities  (as reported)54,525
Long-term Liabilities  (calculated)30,294
+/- 24,230
Total Stockholder Equity
Retained Earnings 1,433,742
Total Stockholder Equity (as reported)2,247,706
Total Stockholder Equity (calculated)1,433,742
+/- 813,964
Other
Capital Stock153,399
Common Stock Shares Outstanding 153,399
Net Invested Capital 2,327,151
Net Working Capital 908,950
Property Plant and Equipment Gross 450,703



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302003-12-312002-12-312001-12-31
> Total Assets 
398,416
453,855
532,624
927,752
872,853
924,493
906,087
928,430
1,172,325
1,060,972
1,072,239
1,020,750
1,063,653
1,051,794
1,058,061
1,104,597
882,151
885,696
962,405
1,198,837
1,189,374
1,159,032
1,384,776
1,259,948
1,291,039
1,296,103
1,342,796
1,186,158
1,274,229
1,077,594
1,175,042
1,183,988
1,183,800
1,168,258
1,306,197
1,248,980
1,236,943
1,260,997
1,460,463
1,468,512
1,414,479
1,445,383
1,491,800
1,469,686
1,490,358
1,546,818
1,647,190
1,568,872
1,588,238
1,602,080
1,654,001
1,647,400
1,700,493
1,807,797
1,807,093
1,793,844
1,833,059
1,924,156
1,839,593
1,871,389
1,670,092
1,722,183
1,727,510
1,777,305
1,834,733
1,928,541
1,992,448
2,011,186
2,186,607
2,417,177
2,563,553
2,584,719
2,677,610
2,825,602
2,970,623
2,928,516
3,247,357
3,437,659
3,666,151
3,688,729
3,916,169
4,167,951
4,167,9513,916,1693,688,7293,666,1513,437,6593,247,3572,928,5162,970,6232,825,6022,677,6102,584,7192,563,5532,417,1772,186,6072,011,1861,992,4481,928,5411,834,7331,777,3051,727,5101,722,1831,670,0921,871,3891,839,5931,924,1561,833,0591,793,8441,807,0931,807,7971,700,4931,647,4001,654,0011,602,0801,588,2381,568,8721,647,1901,546,8181,490,3581,469,6861,491,8001,445,3831,414,4791,468,5121,460,4631,260,9971,236,9431,248,9801,306,1971,168,2581,183,8001,183,9881,175,0421,077,5941,274,2291,186,1581,342,7961,296,1031,291,0391,259,9481,384,7761,159,0321,189,3741,198,837962,405885,696882,1511,104,5971,058,0611,051,7941,063,6531,020,7501,072,2391,060,9721,172,325928,430906,087924,493872,853927,752532,624453,855398,416
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,301,517
1,052,783
1,097,869
1,098,622
1,135,227
1,192,056
1,170,699
1,237,768
1,206,786
1,345,265
1,513,097
1,623,233
1,708,468
1,750,450
1,853,468
2,003,573
1,964,768
2,297,415
2,304,737
2,717,075
2,462,700
2,579,252
2,765,892
2,765,8922,579,2522,462,7002,717,0752,304,7372,297,4151,964,7682,003,5731,853,4681,750,4501,708,4681,623,2331,513,0971,345,2651,206,7861,237,7681,170,6991,192,0561,135,2271,098,6221,097,8691,052,7831,301,51700000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
144,146
87,147
82,810
90,829
108,445
58,551
144,256
117,700
107,417
101,395
91,171
124,572
179,502
295,618
298,363
272,062
202,502
200,347
219,334
366,162
399,342
123,865
305,122
305,122123,865399,342366,162219,334200,347202,502272,062298,363295,618179,502124,57291,171101,395107,417117,700144,25658,551108,44590,82982,81087,147144,14600000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
305,100
0
377,599
358,555
336,566
344,269
332,167
341,355
400,033
427,349
485,792
445,404
471,991
487,132
538,628
496,603
663,207
749,061
641,376
709,201
455,510
795,676
694,456
694,456795,676455,510709,201641,376749,061663,207496,603538,628487,132471,991445,404485,792427,349400,033341,355332,167344,269336,566358,555377,5990305,10000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
51,037
74,771
100,718
139,229
121,758
172,189
158,596
150,026
209,994
270,928
261,715
247,936
277,604
240,653
257,150
282,858
224,423
234,451
221,270
279,102
269,147
284,332
220,499
312,911
324,268
351,715
370,669
278,150
325,636
176,096
244,278
336,975
366,934
305,252
451,901
441,660
435,942
353,681
564,802
609,586
616,173
526,770
563,388
595,850
610,989
524,929
586,328
572,170
665,843
577,849
645,887
604,767
650,988
665,274
716,462
673,894
695,014
737,713
656,908
610,269
425,424
448,968
357,022
404,482
439,324
515,760
584,400
532,899
656,157
595,167
761,537
800,424
756,493
691,476
913,616
809,559
1,005,104
918,291
892,112
1,199,297
942,787
858,462
858,462942,7871,199,297892,112918,2911,005,104809,559913,616691,476756,493800,424761,537595,167656,157532,899584,400515,760439,324404,482357,022448,968425,424610,269656,908737,713695,014673,894716,462665,274650,988604,767645,887577,849665,843572,170586,328524,929610,989595,850563,388526,770616,173609,586564,802353,681435,942441,660451,901305,252366,934336,975244,278176,096325,636278,150370,669351,715324,268312,911220,499284,332269,147279,102221,270234,451224,423282,858257,150240,653277,604247,936261,715270,928209,994150,026158,596172,189121,758139,229100,71874,77151,037
       Other Current Assets 
11,644
5,426
9,754
6,451
9,840
6,355
18,387
17,497
47,097
14,662
24,322
20,075
34,550
26,361
30,024
36,355
15,832
38,180
37,313
40,890
25,628
30,864
31,308
61,813
29,019
35,531
22,690
46,437
75,503
14,437
185,637
201,528
186,720
180,945
189,218
35,369
40,261
48,642
88,444
77,602
116,226
266,914
263,566
11,942
180,371
25,495
38,618
25,377
359,681
26,919
72,395
26,855
47,729
37,397
212,784
28,713
324,056
25,196
256,040
24,916
314,555
27,725
5,936
7,221
8,308
44,055
66,878
58,676
59,943
111,970
106,985
145,341
87,710
103,267
129,358
134,290
165,483
162,853
40,752
38,969
33,240
44,411
44,41133,24038,96940,752162,853165,483134,290129,358103,26787,710145,341106,985111,97059,94358,67666,87844,0558,3087,2215,93627,725314,55524,916256,04025,196324,05628,713212,78437,39747,72926,85572,39526,919359,68125,37738,61825,495180,37111,942263,566266,914116,22677,60288,44448,64240,26135,369189,218180,945186,720201,528185,63714,43775,50346,43722,69035,53129,01961,81331,30830,86425,62840,89037,31338,18015,83236,35530,02426,36134,55020,07524,32214,66247,09717,49718,3876,3559,8406,4519,7545,42611,644
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
628,888
642,078
642,676
757,842
754,680
804,400
841,342
904,079
940,320
876,251
927,161
972,135
967,050
963,748
949,942
1,132,922
949,076
1,226,028
1,336,917
1,402,059
1,402,0591,336,9171,226,028949,0761,132,922949,942963,748967,050972,135927,161876,251940,320904,079841,342804,400754,680757,842642,676642,078628,88800000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
119,213
155,384
235,377
278,053
277,328
297,595
297,831
326,116
335,081
327,883
292,658
320,642
285,637
310,598
278,015
303,344
264,868
256,189
253,691
275,423
247,566
269,712
242,668
296,814
270,229
299,308
269,245
290,930
264,889
257,623
234,044
253,179
228,964
248,164
225,184
244,753
220,909
243,629
221,882
242,095
218,534
246,278
218,672
222,207
224,683
227,297
221,797
226,352
228,217
231,257
234,562
233,723
242,024
239,685
242,174
248,840
256,101
245,547
248,005
256,619
258,053
273,286
274,645
278,600
294,801
332,753
314,416
350,973
364,845
371,587
375,318
381,610
386,139
380,531
389,393
396,933
407,597
417,647
411,629
430,271
444,470
450,703
450,703444,470430,271411,629417,647407,597396,933389,393380,531386,139381,610375,318371,587364,845350,973314,416332,753294,801278,600274,645273,286258,053256,619248,005245,547256,101248,840242,174239,685242,024233,723234,562231,257228,217226,352221,797227,297224,683222,207218,672246,278218,534242,095221,882243,629220,909244,753225,184248,164228,964253,179234,044257,623264,889290,930269,245299,308270,229296,814242,668269,712247,566275,423253,691256,189264,868303,344278,015310,598285,637320,642292,658327,883335,081326,116297,831297,595277,328278,053235,377155,384119,213
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,480
3,480
3,480
3,480
3,480
3,480
3,480
3,480
3,480
3,480
3,480
3,480
3,480
3,480
3,480
3,480
3,202
3,202
214
214
214
214
214
214
214
214
214
214
214
214
214
214
214
214
214
214
214
214
214
214
2142142142142142142142142142142142142142142142142142142142142142143,2023,2023,4803,4803,4803,4803,4803,4803,4803,4803,4803,4803,4803,4803,4803,4803,4803,480000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
207,156
258,378
230,209
233,220
247,211
233,188
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000233,188247,211233,220230,209258,378207,15600000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
20,013
22,474
27,153
26,825
27,058
32,895
32,882
33,097
173,513
32,103
31,957
31,777
31,633
31,318
31,183
30,926
28,921
25,271
24,898
24,954
24,795
25,979
26,019
25,860
25,687
1,326
26,397
1,166
24,574
1,695
24,016
1,618
23,659
1,503
23,123
1,302
22,790
1,102
22,682
890
23,043
1,122
25,415
25,269
25,076
24,913
24,720
24,527
24,334
24,141
23,948
23,755
23,562
23,369
23,176
23,032
22,836
23,470
23,016
22,716
22,361
22,697
41,810
24,982
40,099
41,162
40,781
40,416
42,364
43,397
43,612
43,245
43,031
43,186
43,290
43,012
42,310
42,285
44,414
44,095
43,688
33,987
33,98743,68844,09544,41442,28542,31043,01243,29043,18643,03143,24543,61243,39742,36440,41640,78141,16240,09924,98241,81022,69722,36122,71623,01623,47022,83623,03223,17623,36923,56223,75523,94824,14124,33424,52724,72024,91325,07625,26925,4151,12223,04389022,6821,10222,7901,30223,1231,50323,6591,61824,0161,69524,5741,16626,3971,32625,68725,86026,01925,97924,79524,95424,89825,27128,92130,92631,18331,31831,63331,77731,95732,103173,51333,09732,88232,89527,05826,82527,15322,47420,013
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,613
3,613
3,627
17,761
30,146
10,323
8,549
379,236
11,291
9,742
22,299
20,177
21,858
10,533
18,983
23,270
24,527
17,583
23,084
12,379
12,37923,08417,58324,52723,27018,98310,53321,85820,17722,2999,74211,291379,2368,54910,32330,14617,7613,6273,6133,61300000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
164,851
193,318
242,308
235,550
173,427
219,376
193,331
215,416
345,439
301,325
309,230
255,572
292,570
285,182
282,070
325,260
131,783
143,070
217,121
443,575
430,168
397,796
612,425
465,402
483,844
475,788
533,495
356,251
423,391
228,785
312,191
348,828
318,657
291,285
398,584
378,848
348,605
357,901
521,626
563,661
488,158
504,921
522,672
524,771
503,746
544,793
618,373
578,171
603,258
604,722
633,550
639,284
677,401
776,452
757,643
729,278
744,133
816,709
712,855
746,580
533,676
577,110
553,935
605,108
644,748
720,625
765,537
776,479
885,653
1,093,915
1,207,952
1,185,491
1,184,286
1,257,350
1,311,756
1,280,879
1,469,360
1,569,825
1,696,783
1,713,175
1,772,875
1,911,467
1,911,4671,772,8751,713,1751,696,7831,569,8251,469,3601,280,8791,311,7561,257,3501,184,2861,185,4911,207,9521,093,915885,653776,479765,537720,625644,748605,108553,935577,110533,676746,580712,855816,709744,133729,278757,643776,452677,401639,284633,550604,722603,258578,171618,373544,793503,746524,771522,672504,921488,158563,661521,626357,901348,605378,848398,584291,285318,657348,828312,191228,785423,391356,251533,495475,788483,844465,402612,425397,796430,168443,575217,121143,070131,783325,260282,070285,182292,570255,572309,230301,325345,439215,416193,331219,376173,427235,550242,308193,318164,851
   > Total Current Liabilities 
157,302
175,918
192,933
185,589
123,596
173,371
147,326
168,121
298,835
299,395
309,223
234,975
290,933
284,805
281,914
324,571
130,296
141,945
214,852
442,579
429,252
396,966
611,562
464,398
482,405
475,091
531,987
354,734
421,834
228,485
311,066
348,703
318,532
290,340
397,375
377,639
347,396
347,975
511,739
553,821
478,351
490,476
508,330
510,429
489,253
529,297
602,542
562,341
587,335
592,267
620,756
625,490
663,277
759,077
739,168
712,163
736,246
804,272
700,918
727,737
513,945
560,977
534,860
584,798
623,594
698,342
743,332
753,811
861,923
1,067,659
1,180,973
1,154,000
1,152,541
1,220,054
1,272,522
1,253,093
1,431,957
1,533,678
1,655,005
1,671,970
1,719,270
1,856,942
1,856,9421,719,2701,671,9701,655,0051,533,6781,431,9571,253,0931,272,5221,220,0541,152,5411,154,0001,180,9731,067,659861,923753,811743,332698,342623,594584,798534,860560,977513,945727,737700,918804,272736,246712,163739,168759,077663,277625,490620,756592,267587,335562,341602,542529,297489,253510,429508,330490,476478,351553,821511,739347,975347,396377,639397,375290,340318,532348,703311,066228,485421,834354,734531,987475,091482,405464,398611,562396,966429,252442,579214,852141,945130,296324,571281,914284,805290,933234,975309,223299,395298,835168,121147,326173,371123,596185,589192,933175,918157,302
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,000
20,000
20,000
20,000
12,000
45,000
45,000
45,000
30,000
43,500
22,516
78,461
88,461
88,461
79,445
79,44588,46188,46178,46122,51643,50030,00045,00045,00045,00012,00020,00020,00020,00020,0000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
22,449
38,699
36,626
48,338
31,802
55,957
50,670
42,023
110,286
128,634
152,743
135,684
163,753
154,798
182,308
174,628
46,402
41,162
45,082
234,335
218,907
224,044
523,501
376,650
415,194
359,720
411,160
219,771
267,840
111,810
190,764
192,788
185,238
140,667
249,066
218,327
189,941
194,309
306,475
288,939
209,685
208,275
181,382
171,430
141,485
171,599
179,459
172,654
182,434
195,031
224,888
235,108
247,722
269,801
280,206
251,194
261,742
251,539
189,246
180,534
152,020
201,418
165,487
170,310
173,950
237,116
236,978
189,131
235,266
375,862
397,454
302,522
323,290
372,288
417,242
427,520
545,192
611,065
612,296
580,966
612,743
782,911
782,911612,743580,966612,296611,065545,192427,520417,242372,288323,290302,522397,454375,862235,266189,131236,978237,116173,950170,310165,487201,418152,020180,534189,246251,539261,742251,194280,206269,801247,722235,108224,888195,031182,434172,654179,459171,599141,485171,430181,382208,275209,685288,939306,475194,309189,941218,327249,066140,667185,238192,788190,764111,810267,840219,771411,160359,720415,194376,650523,501224,044218,907234,33545,08241,16246,402174,628182,308154,798163,753135,684152,743128,634110,28642,02350,67055,95731,80248,33836,62638,69922,449
       Other Current Liabilities 
105,848
119,104
111,379
98,651
82,594
108,214
87,356
81,998
134,289
82,386
68,105
54,291
52,180
70,007
44,606
94,943
53,894
50,783
49,770
62,744
74,845
92,922
83,061
86,564
67,211
115,371
120,827
132,963
153,994
116,675
100,302
105,915
93,294
119,673
143,309
154,312
152,455
153,666
205,264
264,882
268,666
282,201
326,948
308,999
317,768
327,698
393,083
359,687
374,901
367,235
365,867
390,382
415,554
479,607
424,033
428,290
449,503
552,733
511,671
228,237
113,681
101,989
233,950
262,709
303,937
127,382
149,080
129,042
152,963
185,666
745,673
210,245
762,585
207,609
781,693
188,430
811,848
272,439
661,949
237,064
720,849
676,329
676,329720,849237,064661,949272,439811,848188,430781,693207,609762,585210,245745,673185,666152,963129,042149,080127,382303,937262,709233,950101,989113,681228,237511,671552,733449,503428,290424,033479,607415,554390,382365,867367,235374,901359,687393,083327,698317,768308,999326,948282,201268,666264,882205,264153,666152,455154,312143,309119,67393,294105,915100,302116,675153,994132,963120,827115,37167,21186,56483,06192,92274,84562,74449,77050,78353,89494,94344,60670,00752,18054,29168,10582,386134,28981,99887,356108,21482,59498,651111,379119,104105,848
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,075
20,310
21,154
22,283
22,205
22,667
23,730
26,256
26,979
31,492
31,744
37,296
39,234
27,786
37,403
36,147
41,778
41,206
53,605
54,525
54,52553,60541,20641,77836,14737,40327,78639,23437,29631,74431,49226,97926,25623,73022,66722,20522,28321,15420,31019,07500000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,734
8,220
9,057
15,841
23,481
26,219
24,144
36,194
30,294
30,29436,19424,14426,21923,48115,8419,0578,2208,7340000000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,977
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000001,97700000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,050
33,461
54,143
55,600
51,231
49,214
82,107
81,995
82,569
84,134
98,384
97,921
95,805
95,752
83,466
82,067
81,086
80,165
91,664
0
0
0
0
000091,66480,16581,08682,06783,46695,75295,80597,92198,38484,13482,56981,99582,10749,21451,23155,60054,14333,46133,05000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
218,153
236,875
263,910
664,199
668,902
675,715
679,588
682,639
691,573
695,841
699,730
702,068
708,494
703,390
712,524
717,180
722,212
716,591
719,285
724,962
728,352
733,936
744,837
748,552
760,742
776,385
765,422
781,029
802,935
821,660
836,276
808,280
837,625
852,568
872,818
834,776
855,336
875,454
900,671
866,259
897,551
913,066
940,730
916,050
957,184
971,720
997,236
958,398
967,210
980,183
1,003,260
991,908
1,006,161
1,014,159
1,031,860
1,046,981
1,071,332
1,089,597
1,118,520
1,116,410
1,131,412
1,139,761
1,168,041
1,166,267
1,183,777
1,201,460
1,220,369
1,227,976
1,294,928
1,316,908
1,349,004
1,392,574
1,486,228
1,561,214
1,651,781
1,640,424
1,770,425
1,862,862
1,964,141
1,969,720
2,134,857
2,247,706
2,247,7062,134,8571,969,7201,964,1411,862,8621,770,4251,640,4241,651,7811,561,2141,486,2281,392,5741,349,0041,316,9081,294,9281,227,9761,220,3691,201,4601,183,7771,166,2671,168,0411,139,7611,131,4121,116,4101,118,5201,089,5971,071,3321,046,9811,031,8601,014,1591,006,161991,9081,003,260980,183967,210958,398997,236971,720957,184916,050940,730913,066897,551866,259900,671875,454855,336834,776872,818852,568837,625808,280836,276821,660802,935781,029765,422776,385760,742748,552744,837733,936728,352724,962719,285716,591722,212717,180712,524703,390708,494702,068699,730695,841691,573682,639679,588675,715668,902664,199263,910236,875218,153
   Common Stock
41,699
41,699
41,699
76,699
76,699
76,699
76,699
76,699
76,699
76,699
76,699
76,699
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
153,399
0
0
0
0
0000153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,399153,39976,69976,69976,69976,69976,69976,69976,69976,69976,69941,69941,69941,699
   Retained Earnings 
74,945
82,943
102,870
112,264
116,993
115,954
119,827
122,142
131,076
130,871
134,760
137,098
146,164
139,960
148,777
152,759
157,791
158,787
161,678
167,545
171,175
173,397
184,108
188,118
199,826
210,526
202,010
217,571
239,251
250,165
264,781
240,342
266,131
272,929
293,179
255,137
275,697
286,876
312,093
277,681
308,973
316,099
467,725
443,045
484,180
497,741
523,256
486,823
511,976
524,950
548,026
536,256
550,509
558,925
576,626
591,747
616,098
634,363
663,286
661,176
676,552
684,901
566,340
564,566
582,076
746,600
765,509
773,117
841,729
863,709
934,143
974,853
1,064,801
1,132,437
1,221,146
1,207,911
1,335,604
1,215,288
1,168,207
1,167,619
1,327,408
1,433,742
1,433,7421,327,4081,167,6191,168,2071,215,2881,335,6041,207,9111,221,1461,132,4371,064,801974,853934,143863,709841,729773,117765,509746,600582,076564,566566,340684,901676,552661,176663,286634,363616,098591,747576,626558,925550,509536,256548,026524,950511,976486,823523,256497,741484,180443,045467,725316,099308,973277,681312,093286,876275,697255,137293,179272,929266,131240,342264,781250,165239,251217,571202,010210,526199,826188,118184,108173,397171,175167,545161,678158,787157,791152,759148,777139,960146,164137,098134,760130,871131,076122,142119,827115,954116,993112,264102,87082,94374,945
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000-2,86000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
200
200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000020020020000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,213,155
Cost of Revenue-2,273,132
Gross Profit1,940,0221,940,022
 
Operating Income (+$)
Gross Profit1,940,022
Operating Expense-3,851,404
Operating Income361,751-1,911,381
 
Operating Expense (+$)
Research Development74,049
Selling General Administrative1,386,814
Selling And Marketing Expenses0
Operating Expense3,851,4041,460,863
 
Net Interest Income (+$)
Interest Income3,732
Interest Expense-3,699
Other Finance Cost-1,121
Net Interest Income-1,088
 
Pretax Income (+$)
Operating Income361,751
Net Interest Income-1,088
Other Non-Operating Income Expenses0
Income Before Tax (EBT)571,094361,751
EBIT - interestExpense = -3,699
521,458
525,156
Interest Expense3,699
Earnings Before Interest and Taxes (EBIT)0574,792
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax571,094
Tax Provision-47,859
Net Income From Continuing Ops523,234523,234
Net Income521,458
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net01,088
 

Technical Analysis of Jianmin Pharmaceutical Group Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jianmin Pharmaceutical Group Co Ltd. The general trend of Jianmin Pharmaceutical Group Co Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jianmin Pharmaceutical Group Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jianmin Pharmaceutical Group Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 58.78 < 60.23 < 61.70.

The bearish price targets are: 52.55 > 52.45 > 44.39.

Tweet this
Jianmin Pharmaceutical Group Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jianmin Pharmaceutical Group Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jianmin Pharmaceutical Group Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jianmin Pharmaceutical Group Co Ltd. The current macd is -0.00573141.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jianmin Pharmaceutical Group Co Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Jianmin Pharmaceutical Group Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Jianmin Pharmaceutical Group Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Jianmin Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartJianmin Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jianmin Pharmaceutical Group Co Ltd. The current adx is 13.15.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Jianmin Pharmaceutical Group Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Jianmin Pharmaceutical Group Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jianmin Pharmaceutical Group Co Ltd. The current sar is 51.46.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Jianmin Pharmaceutical Group Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jianmin Pharmaceutical Group Co Ltd. The current rsi is 49.44. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Jianmin Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) ChartJianmin Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jianmin Pharmaceutical Group Co Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Jianmin Pharmaceutical Group Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Jianmin Pharmaceutical Group Co Ltd Daily Stochastic Oscillator ChartJianmin Pharmaceutical Group Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jianmin Pharmaceutical Group Co Ltd. The current cci is -50.66996552.

Jianmin Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) ChartJianmin Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jianmin Pharmaceutical Group Co Ltd. The current cmo is -1.75133983.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Jianmin Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) ChartJianmin Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jianmin Pharmaceutical Group Co Ltd. The current willr is -36.93430657.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Jianmin Pharmaceutical Group Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Jianmin Pharmaceutical Group Co Ltd Daily Williams %R ChartJianmin Pharmaceutical Group Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jianmin Pharmaceutical Group Co Ltd.

Jianmin Pharmaceutical Group Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jianmin Pharmaceutical Group Co Ltd. The current atr is 2.51868395.

Jianmin Pharmaceutical Group Co Ltd Daily Average True Range (ATR) ChartJianmin Pharmaceutical Group Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jianmin Pharmaceutical Group Co Ltd. The current obv is 43,491,705.

Jianmin Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) ChartJianmin Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jianmin Pharmaceutical Group Co Ltd. The current mfi is 48.16.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Jianmin Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) ChartJianmin Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jianmin Pharmaceutical Group Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Jianmin Pharmaceutical Group Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jianmin Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.440
Ma 20Greater thanMa 5056.273
Ma 50Greater thanMa 10055.738
Ma 100Greater thanMa 20058.811
OpenGreater thanClose55.290
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Jianmin Pharmaceutical Group Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Jianmin Pharmaceutical Group Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jianmin Pharmaceutical Group Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jianmin Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Jianmin Pharmaceutical Group Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Jianmin Pharmaceutical Group Co Ltd.

Receive notifications about Jianmin Pharmaceutical Group Co Ltd in your mailbox!